NR 546 Final Exam Evaluation 2026/2027 |
Verified Questions
Advanced Pharmacology for Psychiatric-Mental Health Nurse Practitioners | Verified
Q&A | PMHNP Students
100 Questions | 2026/2027 Comprehensive Evaluation
Introduction
This original 2026/2027 evaluation contains exactly 100 questions covering Neurobiology and
Psychopharmacology Principles, Management of Mood and Anxiety Disorders, Management of
Psychotic and Neurocognitive Disorders, and Special Populations, Ethics, and Prescribing
Regulations. It reinforces NR 546 objectives, APA-informed guidance, and evidence-based
PMHNP pharmacology for actual-exam readiness and academic success.
Domain: Neurobiology and Psychopharmacology Principles
1. Which PMHNP prescribing principle best supports safe management of
dopamine receptor antagonism?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for dopamine receptor antagonism.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
Rationale: Dopamine Receptor Antagonism requires individualized clinical assessment,
attention to adverse effects and interactions, appropriate monitoring, and patient-centered
education.
2. Which PMHNP prescribing principle best supports safe management of serotonin
reuptake inhibition?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for serotonin reuptake inhibition.
Correct Answer: D
Rationale: Serotonin Reuptake Inhibition requires individualized clinical assessment, attention
to adverse effects and interactions, appropriate monitoring, and patient-centered education.
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
,3. Which PMHNP prescribing principle best supports safe management of
norepinephrine reuptake inhibition?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for norepinephrine reuptake inhibition.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Norepinephrine Reuptake Inhibition requires individualized clinical assessment,
attention to adverse effects and interactions, appropriate monitoring, and patient-centered
education.
4. Which PMHNP prescribing principle best supports safe management of GABA
modulation?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for GABA modulation.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Gaba Modulation requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
5. Which PMHNP prescribing principle best supports safe management of
glutamate modulation?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for glutamate modulation.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
Rationale: Glutamate Modulation requires individualized clinical assessment, attention to
adverse effects and interactions, appropriate monitoring, and patient-centered education.
6. Which PMHNP prescribing principle best supports safe management of partial
agonism?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
, C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for partial agonism.
Correct Answer: D
Rationale: Partial Agonism requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
7. Which PMHNP prescribing principle best supports safe management of
pharmacokinetics?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for pharmacokinetics.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Pharmacokinetics requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
8. Which PMHNP prescribing principle best supports safe management of
pharmacodynamics?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for pharmacodynamics.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Pharmacodynamics requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
9. Which PMHNP prescribing principle best supports safe management of CYP450
inhibition?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for CYP450 inhibition.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
, Rationale: Cyp450 Inhibition requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
10. Which PMHNP prescribing principle best supports safe management of CYP450
induction?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for CYP450 induction.
Correct Answer: D
Rationale: Cyp450 Induction requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
11. Which PMHNP prescribing principle best supports safe management of half-life?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for half-life.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Half-Life requires individualized clinical assessment, attention to adverse effects and
interactions, appropriate monitoring, and patient-centered education.
12. Which PMHNP prescribing principle best supports safe management of steady
state?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for steady state.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Steady State requires individualized clinical assessment, attention to adverse effects
and interactions, appropriate monitoring, and patient-centered education.
13. Which PMHNP prescribing principle best supports safe management of
therapeutic index?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for therapeutic index.
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
Verified Questions
Advanced Pharmacology for Psychiatric-Mental Health Nurse Practitioners | Verified
Q&A | PMHNP Students
100 Questions | 2026/2027 Comprehensive Evaluation
Introduction
This original 2026/2027 evaluation contains exactly 100 questions covering Neurobiology and
Psychopharmacology Principles, Management of Mood and Anxiety Disorders, Management of
Psychotic and Neurocognitive Disorders, and Special Populations, Ethics, and Prescribing
Regulations. It reinforces NR 546 objectives, APA-informed guidance, and evidence-based
PMHNP pharmacology for actual-exam readiness and academic success.
Domain: Neurobiology and Psychopharmacology Principles
1. Which PMHNP prescribing principle best supports safe management of
dopamine receptor antagonism?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for dopamine receptor antagonism.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
Rationale: Dopamine Receptor Antagonism requires individualized clinical assessment,
attention to adverse effects and interactions, appropriate monitoring, and patient-centered
education.
2. Which PMHNP prescribing principle best supports safe management of serotonin
reuptake inhibition?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for serotonin reuptake inhibition.
Correct Answer: D
Rationale: Serotonin Reuptake Inhibition requires individualized clinical assessment, attention
to adverse effects and interactions, appropriate monitoring, and patient-centered education.
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
,3. Which PMHNP prescribing principle best supports safe management of
norepinephrine reuptake inhibition?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for norepinephrine reuptake inhibition.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Norepinephrine Reuptake Inhibition requires individualized clinical assessment,
attention to adverse effects and interactions, appropriate monitoring, and patient-centered
education.
4. Which PMHNP prescribing principle best supports safe management of GABA
modulation?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for GABA modulation.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Gaba Modulation requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
5. Which PMHNP prescribing principle best supports safe management of
glutamate modulation?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for glutamate modulation.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
Rationale: Glutamate Modulation requires individualized clinical assessment, attention to
adverse effects and interactions, appropriate monitoring, and patient-centered education.
6. Which PMHNP prescribing principle best supports safe management of partial
agonism?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
, C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for partial agonism.
Correct Answer: D
Rationale: Partial Agonism requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
7. Which PMHNP prescribing principle best supports safe management of
pharmacokinetics?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for pharmacokinetics.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Pharmacokinetics requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
8. Which PMHNP prescribing principle best supports safe management of
pharmacodynamics?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for pharmacodynamics.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Pharmacodynamics requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
9. Which PMHNP prescribing principle best supports safe management of CYP450
inhibition?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for CYP450 inhibition.
B. Prescribe without assessment or monitoring
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: A
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
, Rationale: Cyp450 Inhibition requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
10. Which PMHNP prescribing principle best supports safe management of CYP450
induction?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use an unverified medication approach
D. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for CYP450 induction.
Correct Answer: D
Rationale: Cyp450 Induction requires individualized clinical assessment, attention to adverse
effects and interactions, appropriate monitoring, and patient-centered education.
11. Which PMHNP prescribing principle best supports safe management of half-life?
A. Prescribe without assessment or monitoring
B. Ignore patient factors and safety risks
C. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for half-life.
D. Use an unverified medication approach
Correct Answer: C
Rationale: Half-Life requires individualized clinical assessment, attention to adverse effects and
interactions, appropriate monitoring, and patient-centered education.
12. Which PMHNP prescribing principle best supports safe management of steady
state?
A. Prescribe without assessment or monitoring
B. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for steady state.
C. Ignore patient factors and safety risks
D. Use an unverified medication approach
Correct Answer: B
Rationale: Steady State requires individualized clinical assessment, attention to adverse effects
and interactions, appropriate monitoring, and patient-centered education.
13. Which PMHNP prescribing principle best supports safe management of
therapeutic index?
A. Use individualized, evidence-informed assessment, monitoring, and shared decision-
making for therapeutic index.
NR 546 Final Exam Evaluation 2026/2027 | Verified Questions
